Loading data
ISPRNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 96.01 m USD | 127.49 m USD | 151.91 m USD | 115.61 m USD | 88.1 m USD |
| Cost of revenue | 83.72 m USD | 104.84 m USD | 122.13 m USD | 94.83 m USD | 74.79 m USD |
| Gross profit | 12.3 m USD | 22.65 m USD | 29.78 m USD | 20.78 m USD | 13.31 m USD |
| Research and development expense | 81.04 k USD | 363.3 k USD | 779.17 k USD | 146.15 k USD | — |
| Operating profit | -32.59 m USD | -37.85 m USD | -13.89 m USD | -4.47 m USD | -988.67 k USD |
| Profit before tax | -32.06 m USD | -38.04 m USD | -13.49 m USD | -4.76 m USD | -803.06 k USD |
| Income tax expense | 1.15 m USD | 1.2 m USD | 1.28 m USD | 1.25 m USD | — |
| Net income (reported basis) | -33.2 m USD | -39.24 m USD | -14.77 m USD | -6 m USD | -1.87 m USD |
| Net income attributable to common shareholders | — | — | — | -6.1 m USD | -1.87 m USD |
| Basic earnings per share | -0.58 USD/share | -0.69 USD/share | -0.27 USD/share | -0.12 USD/share | -0.04 USD/share |
| Diluted earnings per share | -0.58 USD/share | -0.69 USD/share | -0.27 USD/share | -0.12 USD/share | -0.04 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.